Cybin announces roster of 28 expert faculty and advisors for its embark psychedelic facilitator training program

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing “psychedelics to therapeutics™”, today announced the team of 28 esteemed faculty and advisors who will lead the company's embark psychedelic facilitator training program. recognizing the crucial importance of supporting psychedelic study facilitators with quality training, cybin has brought together recognized leaders and senior psychedelic-assisted
CYBN Ratings Summary
CYBN Quant Ranking